Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)

CNY 10.15

(-1.36%)

Total Assets Summary of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest annual total assets in 2023 was 9.52 Billion CNY , down -4.85% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest quarterly total assets in 2024 Q1 was 9.63 Billion CNY , up 1.16% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported annual total assets of 10.01 Billion CNY in 2022, up 21.82% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported annual total assets of 8.21 Billion CNY in 2021, up 6.43% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported quarterly total assets of 9.42 Billion CNY for 2024 Q3, down -3.67% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported quarterly total assets of 9.63 Billion CNY for 2024 Q1, up 1.16% from previous quarter.

Annual Total Assets Chart of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Historical Annual Total Assets of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Year Total Assets Total Assets Growth
2023 9.52 Billion CNY -4.85%
2022 10.01 Billion CNY 21.82%
2021 8.21 Billion CNY 6.43%
2020 7.72 Billion CNY 52.02%
2019 5.07 Billion CNY 49.26%
2018 3.4 Billion CNY 26.26%
2017 2.69 Billion CNY 76.97%
2016 1.52 Billion CNY 17.37%
2015 1.29 Billion CNY -15.76%
2014 1.54 Billion CNY 33.08%
2013 1.15 Billion CNY 0.0%

Peer Total Assets Comparison of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Name Total Assets Total Assets Difference
Shanghai Haoyuan Chemexpress Co., Ltd. 4.19 Billion CNY -127.19%
Hubei Jumpcan Pharmaceutical Co., Ltd. 18.14 Billion CNY 47.506%
Yabao Pharmaceutical Group Co., Ltd 3.85 Billion CNY -147.15%
Shandong Lukang Pharmaceutical Co.,Ltd. 8.8 Billion CNY -8.2%
Zhejiang Huahai Pharmaceutical Co., Ltd. 18.59 Billion CNY 48.794%
Tasly Pharmaceutical Group Co., Ltd 16.71 Billion CNY 43.017%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 10.23 Billion CNY 6.9%
Lionco Pharmaceutical Group Co.,Ltd. 1.62 Billion CNY -486.267%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 2.17 Billion CNY -338.846%
China Animal Husbandry Industry Co., Ltd. 8.94 Billion CNY -6.459%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 7.11 Billion CNY -33.818%
Zhejiang Shengda Bio-Pharm Co., Ltd. 1.71 Billion CNY -453.999%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 6.14 Billion CNY -55.056%
Henan Lingrui Pharmaceutical Co., Ltd. 4.77 Billion CNY -99.59%
Guizhou Yibai Pharmaceutical Co., Ltd. 4.78 Billion CNY -99.238%
Zhongzhu Healthcare Holding Co.,Ltd 3.01 Billion CNY -215.497%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2.87 Billion CNY -231.084%
Jianmin Pharmaceutical Group Co.,Ltd. 4.16 Billion CNY -128.512%
North China Pharmaceutical Company Ltd. 20.95 Billion CNY 54.553%
CanSino Biologics Inc. 9.36 Billion CNY -1.651%
Zhejiang Hisun Pharmaceutical Co., Ltd. 17.61 Billion CNY 45.926%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 12.46 Billion CNY 23.597%
ChengDu ShengNuo Biotec Co.,Ltd. 1.31 Billion CNY -623.88%
Dali Pharmaceuticalco.,Ltd 473.83 Million CNY -1910.043%
Harbin Pharmaceutical Group Co., Ltd. 14.11 Billion CNY 32.51%
Zhejiang Medicine Co., Ltd. 12.77 Billion CNY 25.473%
HPGC Renmintongtai Pharmaceutical Corporation 7.42 Billion CNY -28.248%
Humanwell Healthcare (Group) Co.,Ltd. 36.2 Billion CNY 73.693%
Ginwa Enterprise (Group) Inc. 2.1 Billion CNY -351.697%
KPC Pharmaceuticals, Inc. 9.59 Billion CNY 0.7%
Changchun BCHT Biotechnology Co. 5.04 Billion CNY -88.74%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 2.2 Billion CNY -331.027%
Ningbo Menovo Pharmaceutical Co., Ltd. 4.42 Billion CNY -115.31%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 10.85 Billion CNY 12.235%
Nanjing Well Pharmaceutical Group Co.,Ltd. 2.27 Billion CNY -317.932%
Joincare Pharmaceutical Group Industry Co.,Ltd. 36.35 Billion CNY 73.804%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 15.49 Billion CNY 38.539%
Chongqing Taiji Industry(Group) Co.,Ltd 14.41 Billion CNY 33.913%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 78.58 Billion CNY 87.881%
China National Medicines Corporation Ltd. 32.45 Billion CNY 70.652%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 1.89 Billion CNY -403.193%
Shenzhen Chipscreen Biosciences Co., Ltd. 3.2 Billion CNY -197.331%
Beijing Tongrentang Co., Ltd 30.08 Billion CNY 68.347%
Tibet Weixinkang Medicine Co., Ltd. 1.77 Billion CNY -436.007%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 114.03 Billion CNY 91.648%
Hunan Fangsheng Pharmaceutical Co., Ltd. 3.08 Billion CNY -209.13%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 11.66 Billion CNY 18.359%
Shanghai Jiaoda Onlly Co.,Ltd 815.09 Million CNY -1068.485%
Jiang Zhong Pharmaceutical Co.,Ltd 6.12 Billion CNY -55.408%
Guobang Pharma Ltd. 10.36 Billion CNY 8.081%
Mayinglong Pharmaceutical Group Co., LTD. 4.82 Billion CNY -97.209%
Cisen Pharmaceutical Co., Ltd. 7.33 Billion CNY -29.797%
Hunan Warrant Pharmaceutical Co.,Ltd 2.17 Billion CNY -337.506%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 2.05 Billion CNY -364.208%
Shandong Buchang Pharmaceuticals Co., Ltd. 20.89 Billion CNY 54.413%
Zhejiang Starry Pharmaceutical Co.,Ltd. 5.51 Billion CNY -72.577%
Kangmei Pharmaceutical Co., Ltd. 14.28 Billion CNY 33.305%
Henan Taloph Pharmaceutical Stock Co.,Ltd 3.57 Billion CNY -166.275%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 4.67 Billion CNY -103.646%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 1.86 Billion CNY -411.228%
Shanghai Shyndec Pharmaceutical Co., Ltd. 19.35 Billion CNY 50.785%
Shanghai Yizhong Pharmaceutical Co., Ltd. 1.57 Billion CNY -505.346%
Tibet Rhodiola Pharmaceutical Holding Co. 4.58 Billion CNY -107.62%
Sichuan Huiyu Pharmaceutical Co., Ltd. 4.68 Billion CNY -103.265%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.85 Billion CNY -233.517%